Test Details: CD22 is a B-Cell marker whose expression is used to differentiate neoplastic cells of B-Cell chronic lymphoproliferative disorders from admixed benign B- cells. It is positive in early B-Cell precursors, Pre-B cells, resting and activated B cells.